Clonal diversity shapes the tumour microenvironment leading to distinct immunotherapy responses in metastatic urothelial carcinoma. Kamatani T, Umeda K, Iwasawa T, Miya F, et al. Nat Commun 2025;16:7995.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kamatani T, Umeda K, Iwasawa T, Miya F, et al. Clonal diversity shapes the tumour microenvironment leading to distinct immunotherapy responses in metastatic urothelial carcinoma. Nat Commun 2025;16:7995.
PMID: 40866351